Live Credit Claim: Connecticut Chapter Meeting: May 19, 2026 -- "When Not to Treat" - Deprescribing and the Art of Doing Less
Less often heals more. In this evidence-forward session, participants articulate how commission bias, care momentum, and anchoring drive overtreatment, then apply deprescribing to PPIs without indication, DOAC monotherapy in AFib with stable CAD, statins, levothyroxine, and peripheral IVs. They recognize and evaluate low‑value tests—syphilis serology in cognitive decline and post‑treatment test‑of‑cure urine cultures—distinguish ASB from UTI, and identify practices that build uncertainty tolerance to sharpen clinical judgment and outcomes.
Availability
On-Demand
Release on May 19, 2026 12:00 AM Central Daylight Time
Expires on Aug 19, 2026
Cost
$0.00
Credit Offered
1 CME Credit
1 Participation Credit
  • Overview
  • Faculty
  • Accreditation
  • Recommended
Learning Objectives
After completing this activity, learners should be able to:
  1. By the end of this talk, participants will be able to:
  2. Articulate the cognitive and systemic forces that drive overtreatment in hospital medicine, including commission bias, care momentum, and anchoring, and recognize how these manifest in everyday hospitalist practice.
  3. Apply deprescribing principles to high-yield inpatient targets including PPIs without clear indication, DOAC monotherapy over concurrent antiplatelet therapy in AFib with stable CAD (EPIC-CAD 2024, JACC meta-analysis 2025), statins in limited life expectancy, levothyroxine in subclinical hypothyroidism and end-of-life settings, and peripheral IV access.
  4. Apply diagnostic stewardship principles to high-yield overtesting targets including syphilis serology in cognitive impairment workup without risk factors and post-treatment test-of-cure urine cultures in asymptomatic patients, recognizing how reflexive ordering creates harmful downstream cascades.
  5. Distinguish asymptomatic bacteriuria from true UTI and apply current guideline-concordant management, including the 2025 AUA/CUA/SUFU recommendation against test-of-cure cultures in asymptomatic patients.
  6. Recognize uncertainty intolerance as a driver of overtreatment and identify practical strategies for building uncertainty tolerance, including structured reflection and reflective group practice, reframing restraint as an active clinical skill rather than passivity.
Faculty
  • Anisha Advani, MD
  • Erin McKnight
  • Christopher Sankey, MD, FACP, SFHM
  • Lauren Culy

Faculty Disclosures
The individuals in control of content for this activity have no relevant relationships with ACCME-defined ineligible companies to disclose unless listed here. Any relevant relationships were mitigated prior to the start of this activity.

Accreditation Statement
The Society of Hospital Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CME Credit Statement
The Society of Hospital Medicine designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

MOC Credit Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00  MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

IOS App Download Powered By